Syndax Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Syndax Pharmaceuticals, Inc. (SNDX) had Shares Outstanding (Cover Page) of 89.30 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 89.30M shares.
- 2026-04-27: Entity Common Stock, Shares Outstanding 88.61M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 88.20M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 86.91M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 89.30M shares 10-Q · filed 2026-08-04 |
| 2026-04-27 | 88.61M shares 10-Q · filed 2026-04-30 |
| 2026-02-23 | 88.20M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 86.91M shares 10-Q · filed 2025-11-03 |
| 2025-08-01 | 86.14M shares 10-Q · filed 2025-08-04 |
| 2025-05-01 | 86.05M shares 10-Q · filed 2025-05-05 |
| 2025-02-24 | 86.02M shares 10-K · filed 2025-03-03 |
| 2024-07-25 | 85.10M shares 10-Q · filed 2024-08-01 |
| 2024-05-01 | 84.99M shares 10-Q · filed 2024-05-08 |
| 2024-02-19 | 84.97M shares 10-K · filed 2024-02-27 |
| 2023-10-27 | 69.64M shares 10-Q · filed 2023-11-02 |
| 2023-07-27 | 69.48M shares 10-Q · filed 2023-08-03 |
| 2023-05-03 | 68.82M shares 10-Q · filed 2023-05-08 |
| 2023-02-24 | 68.44K shares 10-K · filed 2023-02-28 |
| 2022-11-02 | 60.22M shares 10-Q · filed 2022-11-03 |
| 2022-08-05 | 56.57M shares 10-Q · filed 2022-08-08 |
| 2022-05-06 | 56.23M shares 10-Q · filed 2022-05-09 |
| 2022-02-25 | 55.01M shares 10-K · filed 2022-03-01 |
| 2021-11-11 | 49.39M shares 10-Q · filed 2021-11-15 |
| 2021-08-06 | 48.63M shares 10-Q · filed 2021-08-09 |
| 2021-05-10 | 48.25M shares 10-Q · filed 2021-05-11 |
| 2021-03-10 | 48.24M shares 10-K/A · filed 2021-04-30 |
| 2020-11-04 | 40.87M shares 10-Q · filed 2020-11-05 |
| 2020-08-05 | 38.55M shares 10-Q · filed 2020-08-06 |
| 2020-05-06 | 36.09M shares 10-Q · filed 2020-05-07 |
| 2020-03-04 | 30.24M shares 10-K · filed 2020-03-05 |
| 2019-11-06 | 27.14M shares 10-Q · filed 2019-11-07 |
| 2019-08-06 | 27.14M shares 10-Q · filed 2019-08-07 |
| 2019-05-07 | 27.10M shares 10-Q · filed 2019-05-08 |
| 2019-03-06 | 25.00M shares 10-K · filed 2019-03-07 |
| 2018-11-02 | 24.84M shares 10-Q · filed 2018-11-05 |
| 2018-08-06 | 23.36M shares 10-Q · filed 2018-08-08 |
| 2018-05-08 | 24.71M shares 10-Q · filed 2018-05-09 |
| 2018-03-05 | 24.70M shares 10-K · filed 2018-03-08 |
| 2017-11-06 | 24.39M shares 10-Q · filed 2017-11-08 |
| 2017-08-10 | 22.22M shares 10-Q · filed 2017-08-10 |
| 2017-05-02 | 18.26M shares 10-Q · filed 2017-05-09 |
| 2017-03-07 | 18.24M shares 10-K · filed 2017-03-14 |
| 2016-11-07 | 18.19M shares 10-Q · filed 2016-11-14 |
| 2016-08-08 | 17.78M shares 10-Q · filed 2016-08-15 |
| 2016-05-05 | 17.78M shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |